Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The market for artificial organs bionics is primarily driven due to a large number of patients who are in need of organ transplantation due to age-related disorders and growing public awareness about the various diseases. The market is also projected to grow due to the advancements in medical bionic implant and artificial organs procedures. There is also an increase in the incidence of road accidents and injuries leading to amputations which call for artificial organs bionics.
But, the market growth is constrained due to lack of availability of donor organs and bio-artificial organs, and the high cost of the devices and uncertain reimbursement scenarios.The factors which pose as a challenge are the issue of dealing with the side effects like skin irritation and also the high chance of a transplant rejection.
Market Segmentation
The global market for Artificial Organs Bionics can be segmented based on product, technology and the type of fixation. On the basis of products, the market is further sub-segmented into artificial organs and bionics. Artificial organs segment is further sub-segmented into artificial heart, artificial pancreas, artificial kidney, artificial liver, and artificial lungs. Bionics segment is further sub-divided into vision bionics, orthopedic bionic, cardiac bionics, and brain bionics. By technology, the market is sub-segmented into electronic bionics and mechanical bionics. By type of fixation, the market is divided into implantable and externally-worn. Cardiac bionics and brain bionics account for the largest share in this market.
Regional/Geographic Analysis
The global market is geographically segmented into North America, Latin America, Europe, Asia Pacific, Africa and Middle-East. Across the globe,North America is the biggest market in terms of market share, followed by Europe. The market in North America is highly driven due to increasing population and awareness among the patients and the players regarding healthcare facilities and medical tourism. The market in the Asia-Pacific region is projected to grow at the highest CAGR in the forecasted period.
Opportunities
The increasing aging population, large consumer base, high disposable income and rising government initiatives for enhancing healthcare provide promising opportunities for the artificial organs bionics industry. There is also rising awareness in developing countries and the scope of artificial organs in therapeutics are some of the major opportunities for market players.
Key Players
Some of the major players in the artificial organs bionics market include Orthofix International N.V., Biomet, Inc., Medtronic, Inc., Cochlear Ltd., Second Sight Medical Products, Inc., Ossur, St. Jude Medical,Ekso Bionics, Inc., Baxter International, Inc., Asahi Kasei Medical Co., Abiomed Inc., Asahi Kasei Medical Co., Ltd, Berlin Heart GmbH, Boston Scientific Corporation,F Hoffman-La Roche Ltd, Worldheart Corporation,Gambro AB, Lifenet Health, Thoratec Corporation, Jarvik Heart Inc. among others.
The report contains comprehensive analysis on:
--> Global paints and coatings Market Segments
--> Global paints and coatings Market Drivers, Restraints and Opportunities
--> Global paints and coatings Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Global paints and coatings Current Trends
--> Competition & Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Feed Software Market includes
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...